Real-world effectiveness of SGLT2 inhibitors in patients with HF and ESKD: a multicenter cohort study
BackgroundPatients with heart failure (HF) and end-stage kidney disease (ESKD) face a high burden of mortality and hospitalization, yet effective therapeutic options remain limited. While sodium-glucose cotransporter-2 inhibitors (SGLT2i) have demonstrated cardiovascular and renal benefits across va...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2026-01-01
|
| Col·lecció: | Frontiers in Cardiovascular Medicine |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/articles/10.3389/fcvm.2026.1652863/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|